Inhibition of SIK2 with the small molecule ARN‐3236, significantly enhances CRC radiosensitivity by arresting HR‐mediated DNA repair, suggesting a potential therapeutic strategy for overcoming radioresistance in CRC. This evidence concerns the gene SIK2 and colorectal carcinoma.